tirzepatide memphis Yevo GLP Semaglutide & Tirzepatide Flex-Dose 1 mL Injectable

Fix It Re-commit to weekly weigh-ins + monthly DEXA scans or smart-scale body-fat checks

* After subcutaneous administration

What positive outcomes can patients expect from long-term Ozempic therapy

These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers